Profile and investment
| Fund type | Open Ended Investment Company |
|---|---|
| Investment style (stocks) | Market Cap: Large Investment Style: Growth |
| Morningstar category | Health |
| Launch date | 07 Aug 1989 |
| Price currency | USD |
| Domicile | United States |
| Symbol | GGHCX |
| Manager & start date | Justin Livengood 18 Dec 2020 |
| Pricing frequency | Daily |
|---|---|
| Total net assets | 1.37bn USD As of Mar 31 2024 |
| Share class size | 701.63m USD As of Mar 31 2024 |
| Net expense ratio | 1.06% |
| Front end load | 5.50% |
| Deferred load | -- |
| Maximum Redemption Fee | -- |
| Min. initial investment | 1,000.00 USD |
| Min. additional investment | 50.00 USD |
| Initial IRA | 250.00 USD |
| Additional IRA | 25.00 USD |
| Available for sale | United States |
More ▼
Top 5 holdings
| Top 5 holdings as a per cent of portfolio | |||
|---|---|---|---|
| 41.04% | 27.49% | 0.00% | 27.49% |
| Category average | % Net assets | % Short | % Long |
| Company | 1 year change | Portfolio weight | Long allocation |
|---|---|---|---|
| Eli Lilly and Co LLY:NYQ | +70.45% | 9.09% | |
| Boston Scientific Corp BSX:NYQ | +38.26% | 5.32% | |
| Unitedhealth Group Inc UNH:NYQ | +0.61% | 5.24% | |
| Mckesson Corp MCK:NYQ | +49.22% | 4.18% | |
| Merck & Co Inc MRK:NYQ | +7.86% | 3.66% | |
| Per cent of portfolio in top 5 holdings: 27.49% |
Asset type
| US stock | 90.47% |
| Non-US stock | 7.14% |
| Cash | 2.39% |
| US bond | 0.00% |
| Non-US bond | 0.00% |
| Other | 0.00% |
Top 5 sectors
| Healthcare | 97.26% |
| Real Estate | 0.35% |
Top 5 regions
| United States | 90.47% |
| Europe - ex Euro | 4.26% |
| United Kingdom | 2.73% |
| Australasia | 0.15% |
Sector and region weightings are calculated using only long position holdings of the portfolio.
